Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
Endokrinologie
|
November 1, 1974
[Differential diagnosis and differential treatment of carbohydrate tolerance disorders in patients with hyperlipoproteinemia. Behavior of plasma lipids, glucose tolerance, and plasma insulin after glucose load during treatment with clofibrate]
W Bruns, I Rjasanowski, P Wulfert, et al.
Experimental and Clinical Endocrinology
|
February 1, 1985
The frequency of islet cell surface antibodies and antibody-dependent cell-mediated cytotoxicity (ADCC) of mononuclear cells in HLA-typed patients with high diabetes risk
I Rjasanowski, D Michaelis, H Dietz, et al.
Experimental and Clinical Endocrinology
|
August 1, 1983
Protection of insulin secretion by magnesium during islet culture: independence of cAMP/or insulin accumulation
B Ziegler, B Wilke, K P Woltanski, et al.
International Archives of Allergy and Applied Immunology
|
January 1, 1991
Effects of the platelet-activating factor antagonist BN 52021 on anti-islet cytotoxicity of mononuclear cells and serum from type 1 (insulin-dependent) diabetic patients
E Köhler, G Varnai, S Knospe, et al.
Experimental and Clinical Endocrinology
|
May 1, 1989
Ciamexone suppressed anti-islet ADCC of mononuclear cells and serum from type 1 (insulin-dependent) diabetic patients
E Köhler, S Knospe, H J Hahn, et al.
Endokrinologie
|
January 1, 1977
Variations of glucose utilization in muscle and adipose tissue of sand rats (Psammomys obesus) during adaptation to laboratory holding
H Schäfer, E Köhler, S Knospe, et al.
Diabetologia
|
February 1, 2006
Differences in protein and energy metabolism following portal versus systemic administration of insulin in diabetic dogs
E-J Freyse, U Fischer, S Knospe, et al.
Endokrinologie
|
September 1, 1975
[Streptozotocin diabetes in the rat with special reference to glucose utilization by the musculature]
E Köhler, S Knospe, H Schäfer, et al.
Diabetes
|
May 1, 1997
Blood glucose lowering and glucagonostatic effects of glucagon-like peptide I in insulin-deprived diabetic dogs
E J Freyse, T Becher, O El-Hag, et al.
Diabetes Research (Edinburgh, Scotland)
|
September 1, 1990
Beta cell destruction of pancreatic islets transplanted into diabetic BB/OK rats may be reflected by increased antibody-mediated anti-islet cytotoxicity
D Schröder, H Wanka, B Hehmke, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
Endokrinologie
|
November 1, 1974
[Differential diagnosis and differential treatment of carbohydrate tolerance disorders in patients with hyperlipoproteinemia. Behavior of plasma lipids, glucose tolerance, and plasma insulin after glucose load during treatment with clofibrate]
W Bruns, I Rjasanowski, P Wulfert, et al.
Experimental and Clinical Endocrinology
|
February 1, 1985
The frequency of islet cell surface antibodies and antibody-dependent cell-mediated cytotoxicity (ADCC) of mononuclear cells in HLA-typed patients with high diabetes risk
I Rjasanowski, D Michaelis, H Dietz, et al.
Experimental and Clinical Endocrinology
|
August 1, 1983
Protection of insulin secretion by magnesium during islet culture: independence of cAMP/or insulin accumulation
B Ziegler, B Wilke, K P Woltanski, et al.
International Archives of Allergy and Applied Immunology
|
January 1, 1991
Effects of the platelet-activating factor antagonist BN 52021 on anti-islet cytotoxicity of mononuclear cells and serum from type 1 (insulin-dependent) diabetic patients
E Köhler, G Varnai, S Knospe, et al.
Experimental and Clinical Endocrinology
|
May 1, 1989
Ciamexone suppressed anti-islet ADCC of mononuclear cells and serum from type 1 (insulin-dependent) diabetic patients
E Köhler, S Knospe, H J Hahn, et al.
Endokrinologie
|
January 1, 1977
Variations of glucose utilization in muscle and adipose tissue of sand rats (Psammomys obesus) during adaptation to laboratory holding
H Schäfer, E Köhler, S Knospe, et al.
Diabetologia
|
February 1, 2006
Differences in protein and energy metabolism following portal versus systemic administration of insulin in diabetic dogs
E-J Freyse, U Fischer, S Knospe, et al.
Endokrinologie
|
September 1, 1975
[Streptozotocin diabetes in the rat with special reference to glucose utilization by the musculature]
E Köhler, S Knospe, H Schäfer, et al.
Diabetes
|
May 1, 1997
Blood glucose lowering and glucagonostatic effects of glucagon-like peptide I in insulin-deprived diabetic dogs
E J Freyse, T Becher, O El-Hag, et al.
Diabetes Research (Edinburgh, Scotland)
|
September 1, 1990
Beta cell destruction of pancreatic islets transplanted into diabetic BB/OK rats may be reflected by increased antibody-mediated anti-islet cytotoxicity
D Schröder, H Wanka, B Hehmke, et al.
Page
of 5